GO:0003179 heart valve morphogenesis: Developmental Process, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003179 heart valve morphogenesis is the biological process that generates and organizes the structure of a heart valve, encompassing endocardial cushion formation, valve leaflet remodeling, and extracellular matrix organization.
• Hemodynamic forces (blood flow) are a central driver of valve morphogenesis, converting mechanical cues into transcriptional programs via mechanosensitive factors such as egr3.
• Endothelial-to-mesenchymal transition (EndoMT) and focal adhesion signaling are essential cellular mechanisms that build and shape valve leaflets.
• Macrophage lineages contribute to valve development and remodeling, and their dysregulation is linked to myxomatous valve disease.
• Notch signaling and interacting pathways (e.g., TGF-beta, BMP) coordinate valve cell fate specification and tissue patterning.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal testing of candidate genes in heart valve morphogenesis.
Description
Heart valve morphogenesis (GO:0003179) is the developmental process that builds and organizes the structural components of cardiac valves, ensuring unidirectional blood flow and long-term valve function. This process is initiated by endocardial cushion formation, followed by remodeling of the cushion into thin, stratified valve leaflets and supporting structures. Defects in valve morphogenesis cause congenital valve malformations and contribute to adult valve disease, making this process a major focus of cardiovascular research. The cellular and molecular mechanisms underlying valve morphogenesis involve mechanotransduction, endothelial-to-mesenchymal transition (EndoMT), extracellular matrix remodeling, and signaling crosstalk between multiple pathways. Hemodynamic forces are not passive; they actively instruct gene expression programs that drive valve cell differentiation and tissue organization. For example, the mechanosensitive transcription factor gene egr3 is required for cardiac valve morphogenesis in response to flow. Focal adhesions provide the physical link between the extracellular matrix and the cytoskeleton, and they are essential for driving zebrafish heart valve morphogenesis. Macrophage lineages also participate in valve development and remodeling, and their transitions are implicated in myxomatous valve disease. Notch signaling and its interacting pathways coordinate cell fate decisions and tissue patterning during cardiac development and disease. Translational control of furina, a proprotein convertase, is important for left-right patterning, heart morphogenesis, and cardiac valve function, highlighting the role of RNA regulons in valve development. This article synthesizes the current understanding of heart valve morphogenesis, the genes and pathways involved, and the research methods used to study it, with a focus on CRISPR-based models for causal gene validation.
heart valve morphogenesis At A Glance
| GO ID | GO:0003179 |
|---|---|
| GO term | heart valve morphogenesis |
| Ontology | biological_process |
| Synonym | heart valve remodeling, heart valve remodelling |
| Definition | The process in which the structure of a heart valve is generated and organized. |
| Major function | Generation and organization of heart valve structure during development |
| Key cellular events | Endocardial cushion formation, EndoMT, focal adhesion signaling, extracellular matrix remodeling, mechanotransduction |
| Key signaling pathways | Notch, TGF-beta/BMP, hemodynamic mechanotransduction |
| Related disease | Congenital heart valve malformations, myxomatous valve disease |
What Is GO:0003179?
According to the Gene Ontology, GO:0003179 heart valve morphogenesis is defined as the process in which the structure of a heart valve is generated and organized. It is a biological process that includes the formation of endocardial cushions, their remodeling into valve leaflets, and the organization of extracellular matrix and cell populations that give the valve its mature architecture. Synonyms include heart valve remodeling and heart valve remodelling.
Why Is heart valve morphogenesis Important in Cell Biology?
Heart valve morphogenesis is essential for normal cardiac function because valves maintain unidirectional blood flow; defects in this process lead to congenital valve malformations and contribute to adult valve disease, including myxomatous degeneration. Understanding the molecular and cellular mechanisms of valve morphogenesis provides a foundation for identifying therapeutic targets and for modeling valve disease in vitro and in vivo.
• Congenital heart valve malformations arise from disrupted valve morphogenesis and are a major cause of pediatric cardiac morbidity.
• Myxomatous valve disease is linked to macrophage transitions and extracellular matrix remodeling during valve development.
• Hemodynamic forces are required for normal valve morphogenesis, and altered flow can lead to valve defects.
• EndoMT is a critical cellular mechanism in valve formation, and its dysregulation contributes to valve disease.
• Focal adhesion signaling is essential for valve morphogenesis, linking extracellular matrix to cytoskeletal dynamics.
• Mechanosensitive transcription factors such as egr3 translate flow cues into gene expression programs required for valve development.
• Notch signaling coordinates cell fate decisions and tissue patterning in cardiac development and disease.
• Translational control of furina affects left-right patterning, heart morphogenesis, and cardiac valve function.
• CRISPR-based models enable causal testing of candidate genes in valve morphogenesis.
• Valve morphogenesis research informs tissue engineering and regenerative strategies for valve replacement.
What Happens During heart valve morphogenesis?
Endocardial cushion formation
In simple terms: The heart valve starts as a cushion of cells and matrix that forms in the developing heart tube.
Heart valve morphogenesis begins with the formation of endocardial cushions, which are swellings of extracellular matrix between the endocardium and myocardium in the atrioventricular canal and outflow tract. These cushions are populated by endocardial cells that undergo endothelial-to-mesenchymal transition (EndoMT), a process in which endothelial cells lose their cell-cell junctions and migrate into the cushion matrix. EndoMT is a critical step in valve development, and its regulation is tightly linked to signaling pathways such as Notch and TGF-beta. In zebrafish, EndoMT is required for valve formation, and its disruption leads to valve defects. The cushion provides the cellular and matrix template for subsequent valve remodeling.
Hemodynamic mechanotransduction
In simple terms: Blood flow pushes on the developing valve, and the cells sense this force and change their gene activity.
Hemodynamic forces generated by blood flow are essential drivers of heart valve morphogenesis. The endocardium and valve interstitial cells sense shear stress and pressure, converting these mechanical cues into biochemical signals that regulate gene expression. The mechanosensitive transcription factor gene egr3 is required for cardiac valve morphogenesis and responds to flow in zebrafish. Focal adhesions, which connect the extracellular matrix to the actin cytoskeleton, are essential for transducing mechanical signals during zebrafish heart valve morphogenesis. Disruption of mechanotransduction leads to abnormal valve morphology and function.
Valve leaflet remodeling and extracellular matrix organization
In simple terms: The cushion is sculpted into thin, strong leaflets with organized matrix.
After cushion formation, the valve primordia undergo remodeling into thin, stratified leaflets with organized extracellular matrix (ECM). This involves the deposition and cross-linking of ECM proteins such as collagen and elastin, and the removal of excess tissue by apoptosis and macrophage-mediated remodeling. Macrophage lineages are present in developing valves and contribute to ECM turnover and valve maturation. In myxomatous valve disease, this remodeling process is dysregulated, leading to thickened, weakened leaflets. Notch signaling and interacting pathways coordinate the cellular rearrangements and ECM organization during valve remodeling.
Translational control and RNA regulons
In simple terms: Cells can control valve development by regulating how efficiently mRNAs are translated into proteins.
Translational control is an emerging layer of regulation in heart valve morphogenesis. The proprotein convertase furina is regulated by an RNA regulon, and this translational control is important for left-right patterning, heart morphogenesis, and cardiac valve function. This highlights that valve morphogenesis is not only controlled at the transcriptional level but also by post-transcriptional mechanisms that fine-tune protein levels. Such RNA regulons may coordinate the expression of multiple genes involved in valve development.
Key Genes Involved in GO:0003179 heart valve morphogenesis
The following genes and proteins have been experimentally implicated in heart valve morphogenesis and related processes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| egr3 | Mechanosensitive transcription factor required for cardiac valve morphogenesis | Flow-responsive gene; knockout and overexpression models in zebrafish |
| furina | Proprotein convertase regulated by an RNA regulon; affects left-right patterning and valve function | Translational control; knockout and knock-in models |
| Notch1 | Signaling receptor coordinating cell fate and patterning in cardiac development | Notch pathway studies in valve morphogenesis |
| TGF-beta | Signaling ligand regulating EndoMT and valve remodeling | Pathway crosstalk in valve development |
| BMP | Signaling ligand involved in endocardial cushion formation | Valve development and disease models |
| VEGFA | Angiogenic factor influencing valve morphogenesis | Hemodynamic and signaling studies |
| NFATC1 | Transcription factor downstream of flow and calcium signaling | Valve remodeling and disease |
| KLF2 | Shear-responsive transcription factor | Mechanotransduction in valve development |
| CDH5 | Endothelial adherens junction protein | EndoMT and endothelial integrity |
| ACTA2 | Smooth muscle actin; cytoskeletal component | Valve interstitial cell differentiation |
| FN1 | Fibronectin; extracellular matrix protein | Focal adhesion and ECM remodeling |
| ITGB1 | Integrin beta 1; focal adhesion component | Mechanotransduction in valve morphogenesis |
| MMP2 | Matrix metalloproteinase; ECM degradation | Valve remodeling and macrophage function |
| CD68 | Macrophage marker | Macrophage lineage tracking in valve development |
| SOX9 | Transcription factor in valve development | Endocardial cushion and valve leaflet formation |
| HAS2 | Hyaluronan synthase; ECM component | Cushion expansion and valve morphogenesis |
How Is heart valve morphogenesis Regulated?
Heart valve morphogenesis is regulated by a combination of hemodynamic forces, signaling pathways, and transcriptional and translational control mechanisms. Hemodynamic shear stress activates mechanosensitive transcription factors such as egr3 and KLF2, which in turn regulate downstream target genes required for valve cell differentiation and tissue remodeling. Notch signaling interacts with TGF-beta/BMP pathways to coordinate EndoMT and valve leaflet stratification. Translational control via RNA regulons modulates the expression of furina, which is important for left-right patterning and cardiac valve function. Macrophages contribute to valve remodeling by clearing apoptotic cells and regulating ECM turnover, and their transitions are implicated in myxomatous valve disease. Focal adhesion signaling provides a mechanical link between the ECM and the cytoskeleton, and its disruption impairs valve morphogenesis.
heart valve morphogenesis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Notch1 | Congenital valve malformations | Knockout and point-mutation models in zebrafish and mouse |
| egr3 | Valve morphogenesis defects | Knockout and overexpression in zebrafish |
| furina | Left-right patterning and valve dysfunction | Knockout and knock-in in zebrafish |
| MMP2 | Myxomatous valve disease | Knockout and overexpression in mouse |
| ITGB1 | Focal adhesion-related valve defects | Knockout in zebrafish |
Congenital heart valve malformations
Disruption of heart valve morphogenesis leads to congenital valve malformations, including bicuspid aortic valve and atrioventricular septal defects. These defects arise from abnormal endocardial cushion formation, EndoMT, or valve remodeling. Mutations in Notch pathway components and other signaling genes have been associated with congenital valve disease. Animal models, such as zebrafish with disrupted EndoMT or focal adhesion signaling, recapitulate aspects of these malformations.
Myxomatous valve disease
Myxomatous valve disease is characterized by thickened, weakened valve leaflets with excessive ECM deposition. Macrophage transitions during valve development and disease contribute to myxomatous changes, and dysregulated macrophage function is linked to disease progression. Experimental models targeting macrophage lineages or ECM remodeling genes can provide insight into disease mechanisms.
Valve dysfunction in left-right patterning disorders
Translational control of furina affects left-right patterning, heart morphogenesis, and cardiac valve function, linking RNA regulon dysregulation to valve dysfunction. This suggests that post-transcriptional mechanisms can contribute to valve disease when perturbed.
From heart valve morphogenesis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for valve morphogenesis? | CRISPR knockout in zebrafish or mouse |
| Does a specific point mutation cause valve malformation? | CRISPR point-mutation knock-in in zebrafish |
| Does overexpression of a gene drive valve remodeling? | Transgenic overexpression in zebrafish |
| Where and when is a gene expressed during valve development? | Tagged knock-in reporter (e.g., GFP) |
| Does a gene regulate EndoMT? | Endothelial-specific knockout in mouse |
| Does a gene affect mechanotransduction? | Flow-responsive reporter assays in zebrafish |
How to Study the heart valve morphogenesis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Gene function loss | Testing requirement in valve morphogenesis |
| Ribo-seq | Translational efficiency | Identifying RNA regulons in valve development |
| RNA-seq | Transcriptome changes | Profiling gene expression during valve remodeling |
| Confocal microscopy | Cell morphology and protein localization | Visualizing valve cell behaviors |
| Lineage tracing | Cell origins and fate | Tracking endocardial and macrophage contributions |
| Immunostaining | Protein expression and localization | Detecting Notch and ECM proteins |
| Traction force microscopy | Mechanical forces at focal adhesions | Studying mechanotransduction |
| Flow chamber assays | Shear stress responses | Analyzing mechanosensitive gene expression |
Genetic knockout and knockdown
CRISPR-Cas9 knockout and morpholino knockdown in zebrafish are widely used to test gene function in heart valve morphogenesis. These approaches can reveal requirements for genes such as egr3 and focal adhesion components in valve development. Knockout models in mouse provide complementary insights into mammalian valve morphogenesis.
Transcriptomics and translational profiling
RNA sequencing and ribosome profiling (Ribo-seq) can identify transcriptional and translational changes during valve morphogenesis. Translational control of furina by an RNA regulon was discovered using such approaches, highlighting the importance of post-transcriptional regulation.
Imaging and lineage tracing
Confocal and light-sheet microscopy in zebrafish allow visualization of valve morphogenesis in live embryos. Lineage tracing using fluorescent reporters can track endocardial and macrophage contributions to valve development. These methods are essential for understanding cell behaviors during valve remodeling.
Biochemical and signaling assays
Western blotting, immunostaining, and reporter assays are used to assess Notch, TGF-beta/BMP, and mechanotransduction pathway activity during valve morphogenesis. Focal adhesion dynamics can be studied using traction force microscopy and phospho-focal adhesion kinase staining.
How CRISPR Can Be Used to Study GO:0003179 heart valve morphogenesis
Knockout
CRISPR knockout is used to ablate candidate genes and assess their requirement for heart valve morphogenesis. For example, knockout of egr3 in zebrafish impairs valve morphogenesis, demonstrating its essential role. Knockout of focal adhesion components also disrupts valve development.
Point Mutation
CRISPR point-mutation knock-in allows modeling of specific human variants in valve morphogenesis genes. This approach can test whether a single amino acid change in furina or other genes affects left-right patterning and valve function.
Knock-in
Tagged knock-in (e.g., GFP or epitope tags) enables visualization and biochemical analysis of endogenous proteins during valve morphogenesis. Knock-in of reporter genes can also track gene expression in specific valve cell populations.
Overexpression
Transgenic overexpression of genes such as egr3 or signaling components can drive or disrupt valve morphogenesis, revealing gain-of-function effects. Overexpression models are useful for testing sufficiency of a gene in valve development.
How EDITGENE Supports heart valve morphogenesis Research
Researchers studying heart valve morphogenesis-related genes often need to determine whether a candidate gene is causally involved in valve development or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such causal studies, from knockout to precise point mutations and overexpression models.
Contact EDITGENE today to design your custom CRISPR model for heart valve morphogenesis research.
Frequently Asked Questions About heart valve morphogenesis
What is heart valve morphogenesis GO:0003179?
GO:0003179 heart valve morphogenesis is the biological process in which the structure of a heart valve is generated and organized, including endocardial cushion formation, valve leaflet remodeling, and extracellular matrix organization.
What genes are involved in heart valve morphogenesis?
Key genes include egr3, furina, Notch1, TGF-beta, BMP, and focal adhesion components such as ITGB1.
How do hemodynamics affect heart valve morphogenesis?
Blood flow generates shear stress that is sensed by endocardial cells, activating mechanosensitive transcription factors like egr3 and KLF2 to drive valve development.
What is the role of EndoMT in heart valve morphogenesis?
Endothelial-to-mesenchymal transition (EndoMT) is a critical process where endocardial cells migrate into the cushion matrix to form valve primordia.
What diseases are linked to defective heart valve morphogenesis?
Congenital valve malformations and myxomatous valve disease are linked to disrupted valve morphogenesis.
How can CRISPR be used to study heart valve morphogenesis?
CRISPR knockout, point-mutation knock-in, and overexpression models allow causal testing of candidate genes in valve development.
What model organisms are used to study heart valve morphogenesis?
Zebrafish and mouse are commonly used due to their accessible cardiovascular development and genetic tractability.
What signaling pathways regulate heart valve morphogenesis?
Notch, TGF-beta/BMP, and mechanotransduction pathways are central regulators.
What is the role of macrophages in heart valve morphogenesis?
Macrophages contribute to valve remodeling by clearing apoptotic cells and regulating extracellular matrix turnover.
How does translational control affect heart valve morphogenesis?
RNA regulons can control the translation of genes like furina, affecting left-right patterning and valve function.
Conclusion
Heart valve morphogenesis (GO:0003179) is a complex developmental process driven by hemodynamic forces, EndoMT, and signaling pathways such as Notch and TGF-beta/BMP. Genes like egr3, furina, and focal adhesion components play essential roles, and their dysregulation leads to congenital and adult valve diseases. CRISPR-based models provide powerful tools to dissect the genetic basis of valve morphogenesis and to identify therapeutic targets.
References
- 1. Gunawan F et al.. 2019. Focal adhesions are essential to drive zebrafish heart valve morphogenesis.. J Cell Biol 218(3):1039-1054 PMID: 30635353
- 2. Steed E et al.. 2016. Hemodynamics driven cardiac valve morphogenesis.. Biochim Biophys Acta 1863(7 Pt B):1760-6 PMID: 26608609
- 3. Nagorska A et al.. 2023. Translational control of furina by an RNA regulon is important for left-right patterning, heart morphogenesis and cardiac valve function.. Development 150(23) PMID: 38032088
- 4. Kim AJ et al.. 2021. Macrophage lineages in heart valve development and disease.. Cardiovasc Res 117(3):663-673 PMID: 32170926
- 5. da Silva AR et al.. 2024. egr3 is a mechanosensitive transcription factor gene required for cardiac valve morphogenesis.. Sci Adv 10(20):eadl0633 PMID: 38748804
- 6. MacGrogan D et al.. 2018. Notch and interacting signalling pathways in cardiac development, disease, and regeneration.. Nat Rev Cardiol 15(11):685-704 PMID: 30287945
- 7. Hulin A et al.. 2018. Macrophage Transitions in Heart Valve Development and Myxomatous Valve Disease.. Arterioscler Thromb Vasc Biol 38(3):636-644 PMID: 29348122
- 8. O'Donnell A et al.. 2020. To EndoMT or Not to EndoMT: Zebrafish Heart Valve Development.. Circ Res 126(8):985-987 PMID: 32271684
